Thus, in addition to providing insights into the mechanism of action of metformin, our data could be valuable in supporting the idea that metformin treatment may be beneficial in reversing the CD8+ T‐cell‐exhausted tumour microenvironment in patients with HCC. Here, CD8A is linked to hepatocellular carcinoma.